General
Preferred name
bucillamine
Synonyms
Rimatil ()
SA96 ()
Thiobutarit ()
Bucilant ()
P&D ID
PD013922
CAS
65002-17-7
Tags
available
drug
Drug Status
investigational
approved
Max Phase
Phase 3
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
9
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugCentral
DrugCentral Approved Drugs
MedChem Express Bioactive Compound Library
Natural product-based probes and drugs
NPC Screening Collection
ReFrame library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
28
Properties
(calculated by RDKit )
Molecular Weight
223.03
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
4
Rotatable Bonds
4
Ring Count
0
Aromatic Ring Count
0
cLogP
0.19
TPSA
66.4
Fraction CSP3
0.71
Chiral centers
1.0
Largest ring
0.0
QED
0.51
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Indication
rheumatoid arthritis
MOA
Immunosuppressant
Biosynthetic Origin
Other (Amino Acid)
Therapeutic Indication
Immunomodulator
Therapeutic Class
Immunomodulatory
Pathway
Protein Tyrosine Kinase/RTK
Target
VEGFR
Source data
